BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3260776)

  • 21. Effects of cytokines tumor necrosis factor alpha and interleukin 1 beta on endotoxin-mediated inhibition of endothelium-derived relaxing factor bioactivity and nitric oxide production in vascular endothelium.
    Myers PR; Parker JL; Tanner MA; Adams HR
    Shock; 1994 Jan; 1(1):73-8. PubMed ID: 7743332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells.
    Bogle RG; Coade SB; Moncada S; Pearson JD; Mann GE
    Biochem Biophys Res Commun; 1991 Oct; 180(2):926-32. PubMed ID: 1659406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
    Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR
    Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do enflurane and isoflurane interfere with the release, action, or stability of endothelium-derived relaxing factors?
    Blaise G; Guy C; To Q; Sauvé R
    Can J Anaesth; 1997 May; 44(5 Pt 1):550-8. PubMed ID: 9161752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of EDRF release by native low-density lipoprotein from cultured porcine endothelial cells through intracellular mechanisms.
    Ezaki M; Ikeda M; Tomita I; Tomita T
    J Cardiovasc Pharmacol; 1994 Oct; 24(4):552-8. PubMed ID: 7528837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the release of vasoactive factors from venous and arterial bovine cultured endothelial cells.
    D'Orleans-Juste P; Mitchell JA; Wood EG; Hecker M; Vane JR
    Can J Physiol Pharmacol; 1992 May; 70(5):687-94. PubMed ID: 1423010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the relationship between the endothelium derived relaxant factor and nitric oxide?
    Long CJ; Berkowitz BA
    Life Sci; 1989; 45(1):1-14. PubMed ID: 2664391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery.
    Crack P; Cocks T
    Br J Pharmacol; 1992 Oct; 107(2):566-72. PubMed ID: 1384915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High D-glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions.
    Graier WF; Simecek S; Kukovetz WR; Kostner GM
    Diabetes; 1996 Oct; 45(10):1386-95. PubMed ID: 8826976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium.
    Myers PR; Wright TF; Tanner MA; Ostlund RE
    J Lab Clin Med; 1994 Nov; 124(5):672-83. PubMed ID: 7964125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial cGMP does not regulate basal release of endothelium-derived relaxing factor in culture.
    Marczin N; Ryan US; Catravas JD
    Am J Physiol; 1992 Jul; 263(1 Pt 1):L113-21. PubMed ID: 1379001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increases in endothelial cyclic AMP levels amplify agonist-induced formation of endothelium-derived relaxing factor (EDRF).
    Graier WF; Groschner K; Schmidt K; Kukovetz WR
    Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):345-9. PubMed ID: 1334403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of different relaxing factors by cultured porcine endothelial cells.
    Boulanger C; Hendrickson H; Lorenz RR; Vanhoutte PM
    Circ Res; 1989 Jun; 64(6):1070-8. PubMed ID: 2498003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
    Gryglewski RJ; Trybulec M; Radziszewski W; Swierkosz T; Dudek R; Zembowicz A
    Biomed Biochim Acta; 1988; 47(10-11):S61-6. PubMed ID: 2470361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of the response of venous smooth muscle to arterial endothelium-derived relaxing factor (EDRF) in respect of the role of nitric oxide.
    Vedernikov YP; Gräser T; Tiedt N; Vikhert AM
    Basic Res Cardiol; 1988; 83(2):122-7. PubMed ID: 3260772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The half-life of endothelium-derived relaxing factor released from bovine aortic endothelial cells in culture.
    Angus JA; Cocks TM
    J Physiol; 1987 Jul; 388():71-81. PubMed ID: 3498834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial dysfunction in murine model of systemic sclerosis: tight-skin mice 1.
    Marie I; Bény JL
    J Invest Dermatol; 2002 Dec; 119(6):1379-87. PubMed ID: 12485443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fendiline and calmidazolium enhance the release of endothelium-derived relaxant factor and of prostacyclin from cultured endothelial cells.
    Busse R; Lückhoff A; Winter I; Mülsch A; Pohl U
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):79-84. PubMed ID: 3285226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative pharmacology of EDRF and nitric oxide on vascular strips.
    Hutchinson PJ; Palmer RM; Moncada S
    Eur J Pharmacol; 1987 Sep; 141(3):445-51. PubMed ID: 3499329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shear stress-induced release of nitric oxide from endothelial cells grown on beads.
    Buga GM; Gold ME; Fukuto JM; Ignarro LJ
    Hypertension; 1991 Feb; 17(2):187-93. PubMed ID: 1991651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.